ResMed Inc - Asset Resilience Ratio
ResMed Inc (RMD) has an Asset Resilience Ratio of 16.77% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ResMed Inc total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2025)
This chart shows how ResMed Inc's Asset Resilience Ratio has changed over time. See ResMed Inc shareholders equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down ResMed Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see RMD market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $1.42 Billion | 16.66% |
| Short-term Investments | $9.32 Million | 0.11% |
| Total Liquid Assets | $1.43 Billion | 16.77% |
Asset Resilience Insights
- Good Liquidity Position: ResMed Inc maintains a healthy 16.77% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
ResMed Inc Industry Peers by Asset Resilience Ratio
Compare ResMed Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for ResMed Inc (1999–2025)
The table below shows the annual Asset Resilience Ratio data for ResMed Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 14.96% | $1.22 Billion | $8.17 Billion | +11.31pp |
| 2024-06-30 | 3.64% | $250.39 Million | $6.87 Billion | +0.08pp |
| 2023-06-30 | 3.56% | $240.31 Million | $6.75 Billion | -1.99pp |
| 2022-06-30 | 5.55% | $282.88 Million | $5.10 Billion | -0.69pp |
| 2021-06-30 | 6.25% | $295.28 Million | $4.73 Billion | -3.85pp |
| 2020-06-30 | 10.10% | $463.16 Million | $4.59 Billion | +6.51pp |
| 2019-06-30 | 3.58% | $147.13 Million | $4.11 Billion | -2.50pp |
| 2018-06-30 | 6.08% | $186.20 Million | $3.06 Billion | -9.65pp |
| 2017-06-30 | 15.73% | $545.43 Million | $3.47 Billion | -- |
| 2016-06-30 | 0.00% | $0.00 | $3.26 Billion | -- |
| 2015-06-30 | 0.00% | $0.00 | $2.18 Billion | -- |
| 2014-06-30 | 0.00% | $0.00 | $2.36 Billion | -- |
| 2013-06-30 | 0.00% | $0.00 | $2.21 Billion | -- |
| 2012-06-30 | 0.00% | $0.00 | $2.14 Billion | -- |
| 2011-06-30 | 0.00% | $0.00 | $2.07 Billion | -- |
| 2007-06-30 | 1.59% | $19.95 Million | $1.25 Billion | -0.60pp |
| 2004-06-30 | 2.19% | $12.02 Million | $549.15 Million | +0.77pp |
| 2003-06-30 | 1.42% | $6.53 Million | $459.60 Million | -3.89pp |
| 2002-06-30 | 5.31% | $19.98 Million | $376.19 Million | -16.42pp |
| 2001-06-30 | 21.73% | $62.62 Million | $288.09 Million | +18.52pp |
| 2000-06-30 | 3.21% | $3.71 Million | $115.59 Million | -3.02pp |
| 1999-06-30 | 6.23% | $5.60 Million | $89.90 Million | -- |
About ResMed Inc
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, h… Read more